Molecular mode of action of CGS 9895 at α1β2γ2 GABAA receptors

17Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

γ-aminobutyric type A (GABAA) receptors are the main inhibitory neurotransmitter receptors in the brain and are targets for numerous clinically important drugs such as benzodiazepines, anxiolytics, and anesthetics. Previously, pyrazoloquinoline 2-p-methoxyphenylpyrazolo [4,3-c] quinolin-3(5H)-one (CGS 9895) was described as a positive allosteric modulator acting through the α+/β− interface in the extracellular domain of GABAA receptors. The localization of the binding site was based on a steric hindrance approach, rather than on direct effects of point mutations. In this study we further characterized modulation by this compound which seems to have multiple sites of action. We investigated GABAA receptors expressed in Xenopus laevis oocytes using voltage-clamp electrophysiology. We have identified the α1Y209 residue at the α+/β− interface as a key residue for CGS 9895 modulation. In addition, the interaction between this residue and various structural analogs was characterized, allowing tentative positioning of CGS 9895 versus α1Y209 (rat sequence). Not all compounds were found to be sensitive to mutations at the α1Y209 residue. In addition, the interaction of CGS 9895 with flurazepam was characterized. Flurazepam is hypothesized to act at the same subunit interface in the extracellular domain. We also provide evidence that the GABAA receptor harbors additional modulatory sites for CGS 9895 at each of the subunit interfaces in the transmembrane domain. (Figure presented.) GABAA receptors are the main inhibitory neurotransmitter receptors in the brain and are targets for numerous clinically important drugs such as benzodiazepines, anxiolytics and anesthetics. We have identified the α1 Y209 residue present at the extracellular α+/β− subunit interface as a key residue for the positive allosteric modulation of the GABAA receptor by CGS 9895. This receptor harbors additional modulatory sites for this compound at subunit interfaces in the transmembrane domain.

References Powered by Scopus

GABA<inf>A</inf> receptor channels

1841Citations
N/AReaders
Get full text

Benzodiazepine actions mediated by specific γ-aminobutyric acid(A) receptor subtypes

1089Citations
N/AReaders
Get full text

International Union of Pharmacology. LXX. Subtypes of γ-aminobutyric acid<inf>A</inf> receptors: Classification on the basis of subunit composition, pharmacology, and function. Update

908Citations
N/AReaders
Get full text

Cited by Powered by Scopus

GABA<inf>A</inf> receptor: Positive and negative allosteric modulators

244Citations
N/AReaders
Get full text

The Benzodiazepine Binding Sites of GABA<inf>A</inf> Receptors

188Citations
N/AReaders
Get full text

A Structural look at GABA <inf>A</inf> receptor mutations linked to epilepsy syndromes

65Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Maldifassi, M. C., Baur, R., & Sigel, E. (2016). Molecular mode of action of CGS 9895 at α1β2γ2 GABAA receptors. Journal of Neurochemistry, 722–730. https://doi.org/10.1111/jnc.13711

Readers over time

‘16‘17‘19‘21‘23‘24‘2500.511.52

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 3

43%

Researcher 2

29%

Professor / Associate Prof. 1

14%

Lecturer / Post doc 1

14%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 2

33%

Neuroscience 2

33%

Chemistry 1

17%

Medicine and Dentistry 1

17%

Save time finding and organizing research with Mendeley

Sign up for free
0